Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter? En savoir plus sur Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma. En savoir plus sur Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma.
Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy. En savoir plus sur Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences. En savoir plus sur Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences.
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma. En savoir plus sur Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis. En savoir plus sur Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis.
Mutant Deficient Mismatch Repair/Proficient Mismatch Repair Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients. En savoir plus sur Mutant Deficient Mismatch Repair/Proficient Mismatch Repair Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients.
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer. En savoir plus sur Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer.